Resource Center

Blood Stain. A drug from Baxter is said to have posed a risk of Hepatitis. FDA and firm didn't impose a step to kill any virus in production of Globulin. Company is facing litigation.

Number	20435
Subject	Medicine
Source	Wall Street Journal (New York)
State	NY
Year	1995
Publication Date	July 20, 1995
Summary	This article talks about a possible association between Baxter's intravenous drug called Gammagard and hepatitis. Baxter has pulled the drug off the market. The article says that as many as 350 people worldwide might have contracted the virus from the drug (which is used as a treatment for immune deficiency).
Category	General
Pages	2
Keywords	Baxter;drug;Baxter International Inc.;Gammagard;hepatitis;virus;intravenous;immune deficiency;health;doctors;medicine;health care;patients;sickness;illness
Related Links
Related Video
Ordering info	Want to place an order? Email us or call us at 573-882-3364 (Stories are only available to members of IRE. For membership information, please refer to our membership page)